John Z Ayanian1, Bruce E Landon, Alan M Zaslavsky, Joseph P Newhouse. 1. Affiliations of authors: Department of Health Care Policy, Harvard Medical School, Boston, MA (JZA, BEL, AMZ, JPN); Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (JZA); Department of Health Policy and Management, Harvard School of Public Health, Boston, MA (JZA, JPN); Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA (BEL); Harvard Kennedy School, Cambridge, MA (JPN); National Bureau of Economic Research, Cambridge, MA (JPN; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI (JZA).
Abstract
BACKGROUND: Breast cancer is a leading cause of mortality for women in all racial/ethnic groups. We compared use of mammography by race/ethnicity in Medicare health maintenance organizations (HMOs), preferred provider organizations (PPOs), and traditional Medicare. METHODS: We matched 495 836 women in HMOs and 81 480 women in PPOs who were aged 65 to 69 years during 2009 to women enrolled in traditional Medicare by race/ethnicity, Medicaid eligibility status, and geographic area. We identified mammography use from the Healthcare Effectiveness Data and Information Set for Medicare HMOs and PPOs and from claims data for traditional Medicare with the same specifications. We then compared racial/ethnic differences in rates of mammography in HMOs and PPOs to matched populations in traditional Medicare and estimated differences with z tests. All statistical tests were two-sided. RESULTS: Relative to matched white women, mammography rates were statistically significantly higher for black, Hispanic, and Asian/Pacific Islander women in HMOs (6.1, 5.4, and 0.9 percentage points, respectively; all P ≤ .003) and statistically significantly lower for all three groups in traditional Medicare (3.3, 7.4, and 7.7 percentage points, respectively; all P < .001). Similar improvements in mammography rates also were observed in PPOs among all minority groups relative to traditional Medicare. CONCLUSIONS: Higher rates of mammography in HMOs and PPOs were associated with a reversal of racial and ethnic differences observed in traditional Medicare. These differences may be related to lower patient cost-sharing and better systems to promote preventive services in managed care plans, as well as unmeasured characteristics or beliefs of minority women who enroll in these health plans relative to those in traditional Medicare.
BACKGROUND:Breast cancer is a leading cause of mortality for women in all racial/ethnic groups. We compared use of mammography by race/ethnicity in Medicare health maintenance organizations (HMOs), preferred provider organizations (PPOs), and traditional Medicare. METHODS: We matched 495 836 women in HMOs and 81 480 women in PPOs who were aged 65 to 69 years during 2009 to women enrolled in traditional Medicare by race/ethnicity, Medicaid eligibility status, and geographic area. We identified mammography use from the Healthcare Effectiveness Data and Information Set for Medicare HMOs and PPOs and from claims data for traditional Medicare with the same specifications. We then compared racial/ethnic differences in rates of mammography in HMOs and PPOs to matched populations in traditional Medicare and estimated differences with z tests. All statistical tests were two-sided. RESULTS: Relative to matched white women, mammography rates were statistically significantly higher for black, Hispanic, and Asian/Pacific Islander women in HMOs (6.1, 5.4, and 0.9 percentage points, respectively; all P ≤ .003) and statistically significantly lower for all three groups in traditional Medicare (3.3, 7.4, and 7.7 percentage points, respectively; all P < .001). Similar improvements in mammography rates also were observed in PPOs among all minority groups relative to traditional Medicare. CONCLUSIONS: Higher rates of mammography in HMOs and PPOs were associated with a reversal of racial and ethnic differences observed in traditional Medicare. These differences may be related to lower patient cost-sharing and better systems to promote preventive services in managed care plans, as well as unmeasured characteristics or beliefs of minority women who enroll in these health plans relative to those in traditional Medicare.
Authors: E P McCarthy; R B Burns; S S Coughlin; K M Freund; J Rice; S L Marwill; A Ash; M Shwartz; M A Moskowitz Journal: Ann Intern Med Date: 1998-05-01 Impact factor: 25.391
Authors: John Z Ayanian; Bruce E Landon; Alan M Zaslavsky; Robert C Saunders; L Gregory Pawlson; Joseph P Newhouse Journal: Health Aff (Millwood) Date: 2013-07 Impact factor: 6.301
Authors: Christie Eheman; S Jane Henley; Rachel Ballard-Barbash; Eric J Jacobs; Maria J Schymura; Anne-Michelle Noone; Liping Pan; Robert N Anderson; Janet E Fulton; Betsy A Kohler; Ahmedin Jemal; Elizabeth Ward; Marcus Plescia; Lynn A G Ries; Brenda K Edwards Journal: Cancer Date: 2012-03-28 Impact factor: 6.860
Authors: Nancy L Keating; Mary Beth Landrum; John Z Ayanian; Eric P Winer; Edward Guadagnoli Journal: J Gen Intern Med Date: 2005-01 Impact factor: 5.128
Authors: Susan A Sabatino; Trevor D Thompson; Jacqueline W Miller; Nancy Breen; Mary C White; Erica Breslau; Meredith L Shoemaker Journal: J Womens Health (Larchmt) Date: 2018-09-28 Impact factor: 2.681
Authors: Justin W Timbie; Ashley M Kranz; Maria DeYoreo; Blen Eshete-Roesler; Marc N Elliott; José J Escarce; Mark E Totten; Cheryl L Damberg Journal: Health Serv Res Date: 2020-10-23 Impact factor: 3.402
Authors: Amresh D Hanchate; Michael K Paasche-Orlow; K Sophia Dyer; William E Baker; Chen Feng; James Feldman Journal: Ann Emerg Med Date: 2017-05-27 Impact factor: 5.721
Authors: Soudabeh Fazeli Dehkordy; A Mark Fendrick; Sarah Bell; Neil Kamdar; Emily Kobernik; Vanessa K Dalton; Ruth C Carlos Journal: J Womens Health (Larchmt) Date: 2019-04-13 Impact factor: 2.681
Authors: Jose F Figueroa; Daniel M Blumenthal; Yevgeniy Feyman; Austin B Frakt; Alexander Turchin; Gheorghe Doros; Qi Gao; Yang Song; Karen E Joynt Maddox Journal: JAMA Cardiol Date: 2019-03-01 Impact factor: 14.676